Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Journal of Neuro-Oncology
Journal
Overview
Identity
Overview
Publication Venue For
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors
. 158:33-40.
2022
Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy
. 156:163-172.
2022
Mitochondrial DNA sequence variation and risk of meningioma
. 155:319-324.
2021
Impact of brain metastasis velocity on neurologic death for brain metastasis patients experiencing distant brain failure after initial stereotactic radiosurgery
. 146:285-292.
2020
Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis
. 141:289-301.
2019
Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study
. 140:341-349.
2018
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts
. 140:209-224.
2018
Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes?
. 139:461-467.
2018
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
. 138:163-171.
2018
Handedness and the risk of glioma
. 137:639-644.
2018
Increasing time to postoperative stereotactic radiation therapy for patients with resected brain metastases: investigating clinical outcomes and identifying predictors associated with time to initiation
. 136:545-553.
2018
Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram
. 135:403-411.
2017
Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome
. 133:277-285.
2017
Key rates for the grades and transformation ability of glioma: model simulations and clinical cases
. 133:377-388.
2017
Protein kinase CK2 is important for the function of glioblastoma brain tumor initiating cells
. 132:219-229.
2017
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma
. 129:487-494.
2016
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
. 129:139-146.
2016
What predicts early volumetric edema increase following stereotactic radiosurgery for brain metastases?
. 127:303-311.
2016
Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas
. 125:123-131.
2015
Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas
. 122:585-593.
2015
Survival analysis in patients with newly diagnosed primary glioblastoma multiforme using pre- and post-treatment peritumoral perfusion imaging parameters
. 120:361-370.
2014
Cognition in patients with newly diagnosed brain metastasis: Profiles and implications
. 120:179-185.
2014
CXCL12 secreted from glioma stem cells regulates their proliferation
. 117:43-51.
2014
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro
. 118:61-72.
2014
Reproductive factors and risk of primary brain tumors in women
. 118:297-304.
2014
Prediagnostic body weight and survival in high grade glioma
. 114:79-84.
2013
Mutant tristetraprolin: A potent inhibitor of malignant glioma cell growth
. 113:195-205.
2013
The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer
. 112:467-472.
2013
Stereotactic radiosurgical treatment of brain metastasis of primary tumors that rarely metastasize to the central nervous system
. 109:513-519.
2012
A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma
. 105:639-646.
2011
Phase i and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas
. 105:375-381.
2011
L1 stimulation of human glioma cell motility correlates with FAK activation
. 105:27-44.
2011
Erratum: Cancer susceptibility variants and the risk of adult glioma in a US case-control study (Journal of Neuro-Oncology DOI: 10.1007/s11060-010-0506-0)
. 104:543.
2011
An NF-κB p65-cIAP2 link is necessary for mediating resistance to TNF-α induced cell death in gliomas
. 102:367-381.
2011
Cancer susceptibility variants and the risk of adult glioma in a US case-control study
. 104:535-542.
2011
Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: Results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma
. 101:57-66.
2011
Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme
. 101:179-188.
2011
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
. 100:95-103.
2010
Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth
. 99:177-185.
2010
Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111
. 95:199-209.
2009
Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness
. 85:271-280.
2007
Long-term outcome of patients with intracranial germinoma
. 83:71-79.
2007
Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM)
. 80:261-274.
2006
1p/19q chromosome deletions in metastatic oligodendroglioma
. 80:203-207.
2006
Radiation dosimetry of
131
I-chlorotoxin for targeted radiotherapy in glioma-bearing mice
. 71:113-119.
2005
Genetic and hypoxic regulation of angiogenesis in gliomas
. 70:229-243.
2004
Caspase-1 mediates Fas-induced apoptosis and is up-regulated by interferon-γ in human astrocytoma cells
. 67:167-176.
2004
Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line
. 66:273-284.
2004
Oncolytic viruses: Clinical applications as vectors for the treatment of malignant gliomas
. 65:203-226.
2003
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma
. 65:127-134.
2003
Fas engagement increases expression of interleukin-6 in human glioma cells
. 56:13-19.
2002
Immunotherapy of a murine T cell lymphoma localized to the brain
. 47:1-10.
2000
Adenoid cystic carcinoma metastatic to the dura: Report of two cases
. 44:267-273.
1999
Intraoperative cortical mapping as a guide to the surgical resection of gliomas
. 42:233-245.
1999
Protein kinase C inhibition by UCN-01 induces apoptosis in human glioma cells in a time-dependent fashion
. 41:9-20.
1999
Fabrication and testing of a device capable of reducing the incidence of ventricular shunt promoted metastasis.
. 27:39-46.
1996
Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system
. 26:191-198.
1995
Multiple fraction-per-day radiotherapy for patients with brain stem tumors
. 17:131-138.
1993
Human glioblastoma cells produce 77 amino acid interleukin-8 (IL-8
77
)
. 16:25-34.
1993
Medulloblastoma: tumor biological and clinical perspectives
. 11:1-15.
1991
The chemotherapy of posterior Fossa tumors in childhood
. 5:217-229.
1987
Identity
International Standard Serial Number (issn)
0167-594X
Electronic International Standard Serial Number (eissn)
1573-7373